Lv1
58 积分 2024-09-09 加入
CRH upregulates supervillin through ERK and AKT pathways to promote bladder cancer cell migration
2天前
已完结
The efficacy and safety of PI3K and AKT inhibitors for patients with cancer: A systematic review and network meta-analysis
2天前
已完结
Lenvatinib inhibits cholangiocarcinoma progression by targeting the FGF19/PI3K/AKT signaling pathway
2天前
已完结
PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance
3天前
已完结
RAB3D, upregulated by aryl hydrocarbon receptor (AhR), promotes the progression of prostate cancer by activating the PI3K/AKT signaling pathway
3天前
已完结
Discovery of an Oxycyclohexyl Acid Lysophosphatidic Acid Receptor 1 (LPA1) Antagonist BMS-986278 for the Treatment of Pulmonary Fibrotic Diseases
3天前
已完结
The development of modulators for lysophosphatidic acid receptors: A comprehensive review
3天前
已完结
Structure dependence and species sensitivity of in vivo hepatobiliary toxicity with lysophosphatidic acid receptor 1 (LPA1) antagonists
3天前
已完结
Mechanism of hepatobiliary toxicity of the LPA1 antagonist BMS-986020 developed to treat idiopathic pulmonary fibrosis: Contrasts with BMS-986234 and BMS-986278
3天前
已完结
Efficacy and Safety of Admilparant, an LPA1 Antagonist in Pulmonary Fibrosis: A Phase 2 Randomized Clinical Trial
3天前
已完结
皖公网安备34019202002308
